These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30879472)

  • 1. Covalent binders in drug discovery.
    Vasudevan A; Argiriadi MA; Baranczak A; Friedman MM; Gavrilyuk J; Hobson AD; Hulce JJ; Osman S; Wilson NS
    Prog Med Chem; 2019; 58():1-62. PubMed ID: 30879472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primer on harnessing non-enzymatic post-translational modifications for drug design.
    Long MJC; Ly P; Aye Y
    RSC Med Chem; 2021 Nov; 12(11):1797-1807. PubMed ID: 34825181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted covalent inhibitors for novel therapeutics.
    Zhang J; Gao W; Wang Y; Chang J; Yu B
    Future Med Chem; 2023 Oct; 15(19):1739-1741. PubMed ID: 37791528
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction to "Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications".
    Henning NJ; Manford AG; Spradlin JN; Brittain SM; Zhang E; McKenna JM; Tallarico JA; Schirle M; Rape M; Nomura DK
    J Am Chem Soc; 2023 Sep; 145(38):21142. PubMed ID: 37708357
    [No Abstract]   [Full Text] [Related]  

  • 5. Belantamab mafodotin for the treatment of multiple myeloma.
    Wang B; Wu C; Zhong Q; Ling L; Wu Z; Yu B; Gao X; Zeng H; Yang DH
    Drugs Today (Barc); 2021 Nov; 57(11):653-663. PubMed ID: 34821879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates.
    Kang MS; Kong TWS; Khoo JYX; Loh TP
    Chem Sci; 2021 Oct; 12(41):13613-13647. PubMed ID: 34760149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Antibody-Drug Conjugate Design: Current Clinical Landscape and Future Innovations.
    Gauzy-Lazo L; Sassoon I; Brun MP
    SLAS Discov; 2020 Sep; 25(8):843-868. PubMed ID: 32192384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1.
    Alboreggia G; Udompholkul P; Baggio C; Muzzarelli K; Assar Z; Pellecchia M
    J Med Chem; 2024 May; 67(10):8172-8185. PubMed ID: 38695666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.
    Udompholkul P; Garza-Granados A; Alboreggia G; Baggio C; McGuire J; Pegan SD; Pellecchia M
    J Med Chem; 2023 Jun; 66(12):8159-8169. PubMed ID: 37262387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CovBinderInPDB: A Structure-Based Covalent Binder Database.
    Guo XK; Zhang Y
    J Chem Inf Model; 2022 Dec; 62(23):6057-6068. PubMed ID: 36453831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent Modification of the JH2 Domain of Janus Kinase 2.
    Henry SP; Liosi ME; Ippolito JA; Menges F; Newton AS; Schlessinger J; Jorgensen WL
    ACS Med Chem Lett; 2022 Nov; 13(11):1819-1826. PubMed ID: 36385940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Covalent Inhibitors Allosterically Deactivate the DEDDh Lassa Fever Virus NP Exonuclease from Alternative Distal Sites.
    Huang KW; Chen JW; Hua TY; Chu YY; Chiu TY; Liu JY; Tu CI; Hsu KC; Kao YT; Chu JW; Hsiao YY
    JACS Au; 2021 Dec; 1(12):2315-2327. PubMed ID: 34977900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives.
    Martín-Sabroso C; Lozza I; Torres-Suárez AI; Fraguas-Sánchez AI
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M
    Soulère L; Barbier T; Queneau Y
    Comput Biol Chem; 2021 Jun; 92():107463. PubMed ID: 33677227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease.
    Macchiagodena M; Pagliai M; Karrenbrock M; Guarnieri G; Iannone F; Procacci P
    J Chem Theory Comput; 2020 Nov; 16(11):7160-7172. PubMed ID: 33090785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors.
    Du H; Gao J; Weng G; Ding J; Chai X; Pang J; Kang Y; Li D; Cao D; Hou T
    Nucleic Acids Res; 2021 Jan; 49(D1):D1122-D1129. PubMed ID: 33068433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the anti-ageing effects of polyphenolics: mitigation of oxidative stress.
    Rolt A; Cox LS
    BMC Chem; 2020 Dec; 14(1):50. PubMed ID: 32793891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions.
    Gambini L; Udompholkul P; Salem AF; Baggio C; Pellecchia M
    ChemMedChem; 2020 Nov; 15(22):2176-2184. PubMed ID: 32790900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential binders of the main protease 3CL
    Macchiagodena M; Pagliai M; Procacci P
    Chem Phys Lett; 2020 Jul; 750():137489. PubMed ID: 32313296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.
    Bum-Erdene K; Liu D; Gonzalez-Gutierrez G; Ghozayel MK; Xu D; Meroueh SO
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7131-7139. PubMed ID: 32179690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.